Nassar ZD - Search Results

1

Activation of μ-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice.

Xie N, Gomes FP, Deora V, Gregory K, Vithanage T, Nassar ZD, Cabot PJ, Sturgess D, Shaw PN, Parat MO. Xie N, et al. Among authors: nassar zd. Brain Behav Immun. 2017 Mar;61:244-258. doi: 10.1016/j.bbi.2016.12.002. Epub 2016 Dec 7. Brain Behav Immun. 2017. PMID: 27939249

2

Morphine alters the circulating proteolytic profile in mice: functional consequences on cellular migration and invasion.

Xie N, Khabbazi S, Nassar ZD, Gregory K, Vithanage T, Anand-Apte B, Cabot PJ, Sturgess D, Shaw PN, Parat MO. Xie N, et al. Among authors: nassar zd. FASEB J. 2017 Dec;31(12):5208-5216. doi: 10.1096/fj.201700546R. Epub 2017 Aug 7. FASEB J. 2017. PMID: 28784632 Free PMC article.

3

Effect of Perioperative Opioids on Cancer-Relevant Circulating Parameters: Mu Opioid Receptor and Toll-Like Receptor 4 Activation Potential, and Proteolytic Profile.

Xie N, Matigian N, Vithanage T, Gregory K, Nassar ZD, Cabot PJ, Shaw PN, Kirkpatrick CMJ, Cao KL, Sturgess D, Parat MO. Xie N, et al. Among authors: nassar zd. Clin Cancer Res. 2018 May 15;24(10):2319-2327. doi: 10.1158/1078-0432.CCR-18-0172. Epub 2018 Mar 6. Clin Cancer Res. 2018. PMID: 29511031

4

Morphine decreases the pro-angiogenic interaction between breast cancer cells and macrophages in vitro.

Khabbazi S, Nassar ZD, Goumon Y, Parat MO. Khabbazi S, et al. Among authors: nassar zd. Sci Rep. 2016 Aug 12;6:31572. doi: 10.1038/srep31572. Sci Rep. 2016. PMID: 27514308 Free PMC article.

5

Cavin Family: New Players in the Biology of Caveolae.

Nassar ZD, Parat MO. Nassar ZD, et al. Int Rev Cell Mol Biol. 2015;320:235-305. doi: 10.1016/bs.ircmb.2015.07.009. Epub 2015 Aug 31. Int Rev Cell Mol Biol. 2015. PMID: 26614875 Review.

6

Caveola-forming proteins and prostate cancer.

Nassar ZD, Parat MO. Nassar ZD, et al. Cancer Metastasis Rev. 2020 Jun;39(2):415-433. doi: 10.1007/s10555-020-09874-x. Cancer Metastasis Rev. 2020. PMID: 32358634 Review.

7

Caveola-forming proteins caveolin-1 and PTRF in prostate cancer.

Nassar ZD, Hill MM, Parton RG, Parat MO. Nassar ZD, et al. Nat Rev Urol. 2013 Sep;10(9):529-36. doi: 10.1038/nrurol.2013.168. Epub 2013 Aug 13. Nat Rev Urol. 2013. PMID: 23938946 Review.

8

Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1.

Pu W, Nassar ZD, Khabbazi S, Xie N, McMahon KA, Parton RG, Riggins GJ, Harris JM, Parat MO. Pu W, et al. Among authors: nassar zd. J Neurooncol. 2019 Jun;143(2):207-220. doi: 10.1007/s11060-019-03161-8. Epub 2019 Apr 4. J Neurooncol. 2019. PMID: 30949900

9

PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis.

Nassar ZD, Moon H, Duong T, Neo L, Hill MM, Francois M, Parton RG, Parat MO. Nassar ZD, et al. Oncotarget. 2013 Oct;4(10):1844-55. doi: 10.18632/oncotarget.1300. Oncotarget. 2013. PMID: 24123650 Free PMC article.

10

Non-caveolar caveolin-1 expression in prostate cancer cells promotes lymphangiogenesis.

Nassar ZD, Hill MM, Parton RG, Francois M, Parat MO. Nassar ZD, et al. Oncoscience. 2015 Aug 3;2(7):635-45. doi: 10.18632/oncoscience.180. eCollection 2015. Oncoscience. 2015. PMID: 26328273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

41 results

Search Page